Khalili Lab Members

Katie joined the team in July 2021 after graduating from MIT with a degree in Biological Engineering and a minor in Women’s and Gender Studies. She completes recruitment and retention efforts for Dr. Khalili's ongoing research studies. Katie also supports the development of NLP-based EMR cohort construction.

Jenny joined the team in June 2022. She graduated from the University of Michigan with a BS in Public Health in 2021. She completes recruitment and retention efforts for Dr. Khalili's ongoing research studies. 

Jess joined the team in September 2020. She works as a Clinical Research Project Manager supporting Dr. Khalili's ongoing projects. She graduated from Tufts University in 2018 with a dual degree in Biochemistry and Spanish and is currently an MBA student in the Health Sector Management program at Boston University.

Prasanna joined the team in January 2021, working with both Dr. Khalili and Dr. Tracey Simon of the CTEU. He received his master's degree in data science from Northeastern University, and his primary interests involve applying machine learning and statistics to solve problems related to healthcare. His current projects center on the development of NLP-based EMR cohorts for gastrointestinal diseases and conducting risk analyses to understand the effect of various factors influencing disease progression.

Kevin Casey joined the team in June 2020 as a Data Analyst. He graduated from the Yale School of Public Health with an MPH in epidemiology. Kevin conducts analyses and contributes to papers for IBD-related projects.

Dr. Michaela Tracy is a clinical fellow in Pediatric Gastroenterology at Boston Children's Hospital and a research fellow in the Harvard-wide Pediatric Health Services Research Program. She joined the team in August 2021. Her research focuses on social determinants of health and outcomes in inflammatory bowel disease. She received her MD from the University of Massachusetts Medical School and completed her residency in pediatrics in the Boston Combined Residency Program in Pediatrics, based at Children's Hospital and Boston Medical Center. 

Dr. Daniel DiGiacomo is a clinical and research fellow in allergy and immunology at MGH. He joined Dr. Khalili's lab in the CTEU in July 2021. He received his MD from Tulane University School Of Medicine, MPH in epidemiology from Columbia University, and completed his residency in pediatrics at Children’s National Medical Center. His research interests focus on using inborn errors of immunity as a model to predict treatment responsiveness in refractory inflammatory bowel diseases.

Jennifer is a medical school student at Harvard Medical School. She joined the team in November 2021 as an NIH NRSA Predoctoral fellow. Her research interests include the epidemiology of inflammatory bowel diseases, particularly to understand disease pathogenesis, create predictive models regarding disease course, likely personalized response to specific therapies, and evaluation of novel treatments. She has a bachelors in Neurobiology with a secondary in Global Health and Health Policy from Harvard College and a Master of Science in Global Health Science from the University of Oxford. Prior to starting medical school, she also served as a US Fulbright Student Researcher to Uganda. 

Dr. Emily Walsh Lopes is a Physician Investigator in the CTEU, a gastroenterologist specializing in inflammatory bowel disease (IBD) at MGH, and an Instructor of Medicine at HMS. Her research interests include understanding how dietary, lifestyle, and genetic factors influence the development and course of inflammatory bowel disease as well as methods for studying disease prevention in IBD. Her research has been funded by the American College of Gastroenterology. 

Dr. Lopes earned her MD from New York University School of Medicine. She completed her internal medicine residency, chief residency, general gastroenterology fellowship, and advanced IBD fellowship at MGH. She completed her MPH in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health.

Dr. Kristin Burke is a Physician Investigator in the CTEU, gastroenterologist at the Crohn’s and Colitis Center at MGH and an Instructor of Medicine at HMS.
Dr. Burke earned her MD from the University of Massachusetts Medical School.  She completed her medicine residency and chief resident year at Beth Israel Deaconess Medical Center.  She then completed both general gastroenterology and inflammatory bowel disease fellowships at MGH. She obtained a MPH at Harvard T.H. Chan School of Public Health.

Through large epidemiologic and translational (GWAS, metabolomic, microbiome) studies, Dr. Burke’s primary research focus is in understanding the pathogenesis and treatment outcomes of inflammatory bowel disease and microscopic colitis to bolster precision medicine and enhance patient care. She has received funding from the AGA and a K23 award from the NIH.